New study highlights potential US public health impact of fish oil derived from menhaden

Public Release: 23-Feb-2016

 

Consumption of EPA and DHA omega-3s may reduce the risk of coronary heart disease; reduce health-care costs by $1.7 billion

GOED

A new study published in Lipid Technology highlights the potential positive impact of consumption of oil derived from menhaden, a U.S.-caught fish high in the omega-3s EPA and DHA, on public health across the country. Medical expenditures in the U.S. are the highest in the world, and cardiovascular disease is a leading cause of mortality, costing more than $444 billion each year in direct and indirect costs (1).

The consumption of 1000 mg per day of EPA and DHA omega-3 fatty acids by the at-risk population — as recommended by the American Heart Association — may reduce the risk of a coronary heart disease (CHD) event and reduce nationwide healthcare costs by $1.7 billion. This study determined that the current U.S. menhaden oil supply, sustainably sourced entirely in U.S. waters, could provide the recommended amount of EPA and DHA to all Americans over 55 with CHD.

Additionally, the excess menhaden oil could be used to supply the salmon farming industry, which in turn could help supply all pregnant and lactating women in the U.S. with the recommended weekly servings of oily fish. This is important due to the recent recommendation (2) by the Food and Drug Administration (FDA) that pregnant and breastfeeding women eat 8-12 ounces of fish per week to support fetal neurodevelopment.

According to study author Douglas M. Bibus, PhD, of the University of Minnesota, “Consumption of fish and omega-3 fatty acids are principal tenants of public health recommendations in the U.S. to promote positive health and development. Omega 3 deficiency is now recognized to affect the majority of US citizens and is classified as a preventable cause of disease and death.”

He continued, “The present research highlights that people are not consuming adequate amounts of EPA and DHA, and normalizing dietary intakes of omega 3 has the potential to significantly impact public health while reducing rising health care costs.”

###

Dr. Bibus is available for interviews. Please contact Ellen Schutt, Communications Director at the Global Organization of EPA and DAH Omega-3s, for scheduling.

References:

1. Shanahan, C., R. de Lorimier, Smart prevention-Health care cost savings resulting from the targeted use of dietary supplements. 2014. Available at: http://www.crnusa.org/CRNfoundation/HCCS/chapters/CRNFrostSullivan-fullreport0913.pdf

2. United States Food and Drug Administration, A quantitative assessment of the net effects on fetal neurodevelopment from eating commercial fish. 2014. Available at: http://www.fda.gov/downloads/Food/FoodborneIllnessContaminants/Metals/UCM396785.pdf

  1 comment for “New study highlights potential US public health impact of fish oil derived from menhaden

  1. February 24, 2016 at 3:26 pm

    Reblogged this on Oil-Change Diet and commented:
    Menhaden–yummy! The problem is not that we are not eating enough fish–we are eating too much omega-6 and that is causing a deficiency in omega-3. They compete–if you eat a ton of omega-6 you have to eat a ton of omega-3!

In order to not be misidentified as spam, please mention something in the article.

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: